ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report)’s share price crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $44.20 and traded as high as $46.23. ProShares Ultra Nasdaq Biotechnology shares last traded at $45.42, with a volume of 9,760 shares changing hands.
ProShares Ultra Nasdaq Biotechnology Price Performance
The company has a market capitalization of $49.96 million, a PE ratio of 20.68 and a beta of 1.63. The firm has a 50-day moving average of $44.20 and a 200 day moving average of $49.47.
ProShares Ultra Nasdaq Biotechnology Cuts Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Wednesday, March 26th were issued a $0.1309 dividend. This represents a $0.52 dividend on an annualized basis and a yield of 1.15%. The ex-dividend date was Wednesday, March 26th.
Institutional Inflows and Outflows
ProShares Ultra Nasdaq Biotechnology Company Profile
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
Featured Stories
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- New All-Time Highs Coming for Broadcom? Wall Street Says Yes
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Overheated Market? Analysts Watch These Red Flags
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Reasons AMD Could Be the Hottest Stock of the Summer
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.